Brief: NanoCarrier decides to terminate clinical trial of NC-6004
21/12/2016 09:11
Dec 21 (Reuters) - NanoCarrier Co Ltd 4571.T :
* Says it decides to terminate the first phase of clinical
trial for NC-6004
Source text in Japanese: https://goo.gl/2zh3dq
Further company coverage: 4571.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))